| Entry |
|
|---|
| Name |
Dopamine;
4-(2-Aminoethyl)-1,2-benzenediol;
4-(2-Aminoethyl)benzene-1,2-diol;
3,4-Dihydroxyphenethylamine;
2-(3,4-Dihydroxyphenyl)ethylamine
|
|---|
| Formula |
C8H11NO2
|
|---|
| Exact mass |
153.079
|
|---|
| Mol weight |
153.1784
|
|---|
| Structure |
   |
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Pathway |
| map00950 | Isoquinoline alkaloid biosynthesis |
| map01060 | Biosynthesis of plant secondary metabolites |
| map01063 | Biosynthesis of alkaloids derived from shikimate pathway |
| map01110 | Biosynthesis of secondary metabolites |
| map04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Module |
| M00042 | Catecholamine biosynthesis, tyrosine => dopamine => noradrenaline => adrenaline |
|
|---|
| Enzyme |
|
|---|
| Brite |
Compounds with biological roles [BR:br08001]
Peptides
Amines
Biogenic amines
C03758 Dopamine
Hormones and transmitters
Other hormones
Dopamine
C03758 Dopamine
Neurotransmitters
Biogenic amines
C03758 Dopamine
Phytochemical compounds [BR:br08003]
Alkaloids
Alkaloids derived from tyrosine
Tyramine derivatives
C03758 Dopamine
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C01 CARDIAC THERAPY
C01C CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
C01CA Adrenergic and dopaminergic agents
C01CA04 Dopamine
D07870 Dopamine (INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
DRD
D07870 Dopamine (INN)
Prodrugs [br08324.html]
D07870
 |
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 11
1 C8y C 25.9700 -18.5500
2 C8x C 24.7800 -17.8500
3 C8x C 25.9700 -19.9500
4 C1b C 27.2300 -17.8500
5 C8y C 23.5900 -18.5500
6 C8x C 24.7800 -20.6500
7 C1b C 28.4200 -18.5500
8 C8y C 23.5900 -19.9500
9 O1a O 22.4000 -17.8500
10 N1a N 29.6100 -17.8500
11 O1a O 22.4000 -20.5800
BOND 11
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 2
5 3 6 1
6 4 7 1
7 5 8 1
8 5 9 1
9 7 10 1
10 8 11 1
11 6 8 2
|
|---|
